Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, announces that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”). The Transaction has been unanimously approved by both Masimo’s Board of Directors and Danaher’s Board of Directors. Masimo will become a standalone business unit and brand within Danaher’s Diagnostics segment and will operate autonomously while strengthening Danaher’s offering in acute care settings.
Read the full article: Masimo to Be Acquired by Danaher for $180.00 per Share //
Source: https://www.businesswire.com/news/home/20260217693538/en/Masimo-to-be-Acquired-by-Danaher-for-%24180.00-Per-Share